Agatolimod
Agatolimod (ODN 2006), a class B ODN (oligodeoxynucleotide), is a TLR9 agonist. Agatolimod is also an optimal CpG sequence for humans. Agatolimod stimulates very strong production of NO2 and IL-6 in HD11 cells. Agatolimod can be used for breast cancer research. Sequence: 5'-tcgtcgttttgtcgttttgtcgtt-3'[1][2].
Product Specifications
CAS Number
525625-52-9
Product Name Alternative
ODN 2006; PF-3512676; CpG 7909; ODN 7909
UNSPSC
12352208
Target
Toll-like Receptor (TLR)
Type
Oligonucleotides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/agatolimod.html
Purity
98.49
Smiles
[Agatolimod]
Molecular Formula
C236H326N70O133P23S23
Molecular Weight
7699
References & Citations
[1]Xie H, et al. CpG-induced immunomodulation and intracellular bacterial killing in a chicken macrophage cell line. Dev Comp Immunol. 2003 Oct;27 (9) :823-34.|[2]Babaer D, et al. Oligodeoxynucleotides ODN 2006 and M362 Exert Potent Adjuvant Effect through TLR-9/-6 Synergy to Exaggerate Mammaglobin-A Peptide Specific Cytotoxic CD8+T Lymphocyte Responses against Breast Cancer Cells. Cancers (Basel) . 2019 May 14;11 (5) :672.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Oligonucleotides
Clinical Information
Phase 3
Isoform
TLR9
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2086273-01 0.01 mg
OVA Conjugated Islet Amyloid Polypeptide (IAPP)
Sign In for Pricing
View Details MBS2086273-02 0.05 mg
OVA Conjugated Islet Amyloid Polypeptide (IAPP)
Sign In for Pricing
View Details MBS2086273-03 0.1 mg
OVA Conjugated Islet Amyloid Polypeptide (IAPP)
Sign In for Pricing
View Details MBS2086273-04 0.2 mg
OVA Conjugated Islet Amyloid Polypeptide (IAPP)
Sign In for Pricing
View Details MBS2086273-05 0.5 mg
OVA Conjugated Islet Amyloid Polypeptide (IAPP)
Sign In for Pricing
View Details